PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-51.09%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-44.77%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-95.27%
Negative EBIT growth while 6203.T is at 122.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-95.63%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-93.52%
Negative net income growth while 6203.T stands at 118.53%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-93.52%
Negative EPS growth while 6203.T is at 118.52%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-93.52%
Negative diluted EPS growth while 6203.T is at 118.52%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
175.02%
Positive 10Y revenue/share CAGR while 6203.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
21.78%
Positive 5Y CAGR while 6203.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
21.42%
3Y revenue/share CAGR above 1.5x 6203.T's 5.49%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
131.42%
Net income/share CAGR 1.25-1.5x 6203.T's 90.05%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
128.41%
5Y net income/share CAGR above 1.5x 6203.T's 66.63%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
194.76%
Positive short-term CAGR while 6203.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
138.64%
10Y equity/share CAGR above 1.5x 6203.T's 16.59%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
51.28%
5Y equity/share CAGR above 1.5x 6203.T's 22.16%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
31.75%
3Y equity/share CAGR above 1.5x 6203.T's 13.08%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.18%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
23.38%
Inventory growth well above 6203.T's 19.34%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.02%
Asset growth at 50-75% of 6203.T's 6.62%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.97%
BV/share growth above 1.5x 6203.T's 2.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
17.57%
Debt growth far above 6203.T's 7.58%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-16.18%
We cut SG&A while 6203.T invests at 2.35%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.